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The rotenone-insensitive NADH:hexaammineruthenium III (HAR) oxidoreductase reactions cata-
lyzed by bovine heart and Yarrowia lipolytica submitochondrial particles or puriﬁed bovine complex
I are stimulated by ATP and other purine nucleotides. The soluble fraction of mammalian complex I
(FP) and prokaryotic complex I homolog NDH-1 in Paracoccus denitriﬁcans plasma membrane lack
stimulation of their activities by ATP. The stimulation appears as a decrease in apparent Km values
for NADH and HAR. Thus, the ‘‘accessory’’ subunits of eukaryotic complex I bear an allosteric ATP-
binding site.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The mitochondrial proton-translocating NADH:ubiquinone oxi-
doreductase (respiratory complex I) and its prokaryotic homologue
(NDH-1) catalyze oxidation of intramitochondrial (or cytoplasmic)
NADH, thus maintaining the steady-state NADH/NAD+ ratio re-
quired for coordination between ATP-producing respiration and
anabolic metabolism [1–4]. The mammalian mitochondrial com-
plex I is an enormously large machine composed of 45 different
subunits having total molecular mass of about 1 MDa [5]. The bac-
terial operons encoding NDH-1 contain 13–14 genes [2], and their
transcription products are highly homologous to 14 ‘‘core’’ sub-
units of the mammalian and fungal enzymes. Up to 10 distinct
redox components (FMN, iron–sulfur centers, bound ubiquinone
species) [6–9] buried in the hydrophilic arm of the enzyme
[10,11] electronically connect NADH bound at a site located at
about 100 Å distant from the coupling membrane plane and the
terminal electron acceptor, the membranous quinone/quinol pool.
The catalytic properties of the mammalian [3], fungal [12], and
prokaryotic [13,14] enzymes are similar although not identical.chemical Societies. Published by E
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ogradov).Characteristic L-shaped three-dimensional structures of bovine
heart [15], Neurospora crassa [16], Yarrowia lipolytica [11], Esche-
richia coli [10], and Paracoccus denitriﬁcans [17] complexes have
been visualized. It is generally thought that 13–14-subunit bacte-
rial enzymes represent a minimal structural unit required for the
catalytic activity. The speciﬁc functions of 31 so-called supernu-
merary or accessory subunits of eukaryotic complex I are not clear.
Mammalian SDAP [18] and N. crassa ACP [19] subunits have been
identiﬁed as acyl-carrier protein of fatty acid synthase complex.
The subunit B16.6 (bovine heart nomenclature) is the GRIM-19
apoptosis-inducing factor [20]. A number of the subunits were
shown to be susceptible to posttranslational modiﬁcations such
as phosphorylation [21,22], glutathionylation [23], and acetyla-
tion/de-acetylation [24] although no substantial changes in the
enzymatic activity resulting from these modiﬁcations have been
documented. It seems unlikely that complex I, the enzyme operat-
ing as the major entry to the respiratory chain, is not subjected to
regulation. One such a mechanism, so-called A/D transition [25]
characteristic for a number of eukaryotic species [26] and absent
in prokaryotes, has been described for preparations of various de-
gree of resolution (puriﬁed enzyme [27], inside-out submitochon-
drial particles [28], intact mitochondria [29], and perfused hearts
[30]). No speciﬁc effects of the natural, low molecular mass mito-
chondrial constituents except for free fatty acids [31] have been
described so far.
In this report we will show that ATP in the micromolar concen-
tration range speciﬁcally stimulates the NADH:hexaammineruthe-
nium(III) (HAR) reductase activity catalyzed by eukaryotic complex
I when assayed at low NADH and acceptor concentrations. No suchlsevier B.V. All rights reserved.
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complex I or for P. denitriﬁcansmembrane-bound NDH-1. Although
the physiological signiﬁcance of the ATP-induced effect remains to
be established, our data are the ﬁrst to demonstrate that a func-
tionally signiﬁcant, high-afﬁnity ATP-speciﬁc binding site exists
within accessory subunits of mitochondrial complex I.
2. Materials and methods
Bovine heart submitochondrial particles (SMP)were prepared as
described [28], and their NADH oxidase was activated by aerobic
incubation with NADPH [32]. After activation the SMP were precip-
itated by centrifugation, suspended in a mixture comprised of
0.25 M sucrose, 50 mM Tris–Cl (pH 8.0), and 0.2 mM EDTA–KOH,
0.1 mMpotassiummalonate and stored in liquid nitrogen. Complex
I [33] and its low molecular mass fragment FP [34] were puriﬁed as
described. Y. lipolytica (var. alkalitolerance [35]) mitochondria were
kindly provided by Dr. Renata Zvyagilskaya (A.N. Bach Institute of
Biochemistry, Russian Academy of Sciences). Y. lipolytica submito-
chondrial particles (Y-SMP) were prepared as follows. Mitochon-
dria (15 mg protein) were suspended in 6 ml of 0.15 M sucrose,
and EDTA (1 mM ﬁnal concentration) was added. The suspension
was placed on ice, saturated with argon for 10 min with continuous
stirring, the pH was adjusted to 8.6 with NH4OH, and sonicated
(MSE Soniprep 50, maximal power output) under argon ﬂow
(5 times, 30 s each with 1 min intervals). The suspension was cen-
trifuged for 10 min at 20 000g, the precipitated material was dis-
carded, and the supernatant was centrifuged for 1 h at 120 000g.
The pellet was rinsed with a solution composed of 0.25 M sucrose,
50 mM Tris–Cl buffer (pH 8.0), and 0.2 mM EDTA and suspended in
1 ml of the same solution. The ﬁnal preparation of Y-SMP (3 mg pro-
tein per ml) was stored in liquid nitrogen. About half of the NADH
oxidase activity catalyzed by Y-SMP was sensitive to rotenone
(due to the presence of alternative NADH dehydrogenase, NDH-2)
and deamino-NADH, the speciﬁc substrate for NADH-1 was used
as the substrate when the Y-SMP were analyzed.
NADH oxidase, the NADH:artiﬁcial acceptor reductase, and
other activities were assayed at 30 C in the standard reaction mix-
ture composed of 0.25 M sucrose, 50 mM Tris–Cl (pH 8.0), and
0.2 mM K-EDTA. NADH:HAR reductase activities of SMP and puri-
ﬁed complex I were assayed in the presence of rotenone (5 lM).
Rotenone (5 lM) and KCN (5 mM) were added to the assays when
NADH:HAR reductase activities of Y-SMP and P-PMV were mea-
sured. Antimycin A (1 lg/ml) was present when the rotenone-sen-
sitive NADH:Q1 reductase activity of SMP was assayed. Other
speciﬁc additions to the standard reaction mixture and details
are indicated in the captions to the ﬁgures and footnotes to Table 1.
All the activities reported in Figs. 1, 3 and 4 and in Table 1 were
determined in at least three independent assays with the experi-
mental errors of less than 10%. Wurster’s Blue, the perchlorate salt
of free cation-radical of tetramethyl-p-phenylenediamine (WB)
was prepared as described [36]. All other ﬁne chemicals were from
Sigma–Aldrich (USA).
The protein content was determined by the biuret assay using
bovine serum albumin as the standard.3. Results
The membrane-bound and puriﬁed dispersed mitochondrial
complex I and their prokaryotic homologue NDH-1 catalyze a num-
ber of the NADH:artiﬁcial electron acceptor oxidoreductase activi-
ties showing particularly high turnover numbers with ferricyanide
[37] and hexaammineruthenium(III) [38]. The kinetic patterns of
the steady-state NADH oxidation with these two electron acceptors
are quite different. When assayed at limiting reactant concentra-tions, the ferricyanide reductase reaction proceeds according to a
ping–pong mechanism with inhibition of the reaction rate by both
substrate and acceptor [37], whereas the HAR reductase reaction
proceeds according to the ternary complex or Theorell–Chance
mechanism [38] and no inhibition by excess of either reactant is
seen. These data unequivocally suggest that these two oxidants ac-
cept electrons from different sites of the multi-redox component
complex I. The kinetic patterns ofmammalian complex I in anumber
of its catalytic activities such as forward and reverse electron trans-
fer [39], transhydrogenase reaction [40,41], and superoxide genera-
tion [42] are far from being trivial, and we feel that a closer look at
the reactions with different artiﬁcial electron acceptors would be
insightful. As the ﬁrst step of this strategy, the effect of ADP-ribose
(a competitive inhibitor of the NADH binding site [43]) on the HAR
reductase activity of SMPwas evaluated over a wide range of NADH
concentrations. Fig. 1 demonstrates a non-trivial effect of the com-
petitive inhibitor on HAR reductase, i.e. at low concentration of the
substrate (NADH) ADP-ribose signiﬁcantly stimulated the reaction.
The only plausible explanation for biphasic effect of the competitive
inhibitor as depicted in Fig. 1 seemed to be the presence of a nucle-
otide binding site different from that where NADH binds as the sub-
strate, and this hypothesis was further elaborated. To avoid a
complexity due to dual activation and inhibition by ADP-ribose,
the effects of a simpler nucleotide, ATP, were further investigated.
Fig. 2 demonstrates the effect of ATP on NADH:HAR reductase
as it was seen when different complex I preparations were assayed.
ATP either present in the reaction mixture or added during assay
caused immediate stimulation of the reactions catalyzed by SMP
(A), puriﬁed bovine heart complex I (B), and the other eukaryotic
complex I, Y-SMP (C). No stimulatory effects were seen when
prokaryotic P. denitriﬁcans inside-out plasma membrane vesicles
(P-PMV) (D) or bovine heart FP (not shown) were used as the en-
zyme preparations. Half-maximal stimulation of the activity by
ATP at constant concentration of NADH appeared at 20 lM
(Fig. 3). Since the activating effect of ADP-ribose was evident only
at low NADH concentration, the kinetic pattern of ATP-dependent
stimulatory effect was assessed (Fig. 4), and competitive with
NADH (A) and HAR (B) activation was evident, i.e. the presence
of ATP decreased apparent Km values for both substrates without
affecting the maximal activity.
As depicted in Table 1, other purine nucleotides (ADP, GTP, and
AMP-PNP) also stimulated the NADH:HAR reductase at low NADH
concentration, whereas AMP, adenosine, cAMP, and CTP did not.
The activation by ATP was prevented or reversed by Mg2+, thus
suggesting that free nucleotide, not ATP–Mg complex, binds to
the enzyme.
Itwasof obvious interest to see if other thanHAR reductase activ-
itywould be affected by ATP. The following activities of complex I in
coupled or uncoupled SMP preparations were tested: (i) NADH oxi-
dase measured in the presence of 100 lM NADH or 1 lM NADH
(ethanol and alcohol dehydrogenasewere used as the NADH-regen-
erating system in the latter case); (ii) NADH:ferricyanide reductase;
(iii) NADH:WB reductase [44]; (iv) rotenone-sensitive NADH:Q1
reductase; (v) energy-dependent, succinate-supported reverse elec-
tron transfer activity, (vi) NADH:acetyl-NAD+ transhydrogenase;
(vii) NADH- and succinate-supported superoxide generation. None
of these activitieswas affected byATP under a variety of experimen-
tal conditions (negative results are not shown). ATP also affected
neither the rates of thermally induced deactivation nor the turn-
over-dependent activation of complex I in SMP.4. Discussion
Signiﬁcant stimulation of eukaryotic complex I activity by ATP,
if assayed with low concentration of NADH and HAR, unequivo-
Table 1
Effect of nucleotides on the NADH:HAR reductase activity of complex I in bovine heart submitochondrial particles.
Nucleotide addeda Speciﬁc activityb
(lmol/min per mg)
Apparent Kac (lM) Maximal stimulationd
(fold)
1. None 0.10
2. ATP, 100 lM 0.97 20 10
3. As (2) + Mg2+, 1 mM 0.18
4. As (2) + atractylate, 5 lM 0.72
5. ADP, 100 lM 0.26 100 4.5
6. AMP-PNP, 50 lM 0.24 n.d.e n.d.
7. GTP, 100 lM 0.42 n.d. n.d.
8. GDP, 100 lM 0.13 n.d. n.d.
9. Adenosine, 100 lM 0.10 n.d. n.d.
10. AMP, 100 lM 0.10 n.d. n.d.
11. cAMP, 100 lM 0.10 n.d. n.d.
12. CTP, 100 lM 0.10 n.d. n.d.
a Nucleotides and other additions were added to the standard assay mixture and the reaction was initiated by the addition of SMP.
b Initial rate of 5 lM NADH oxidation in the presence of 50 lM HAR.
c Determined from the double reciprocal plot 1/v versus 1/[nucleotide].
d Ratio of activity in the presence of saturating nucleotide to activity in the absence of nucleotide.
e n.d.: not determined.
Fig. 1. Effect of ADP-ribose on the initial rate of NADH:HAR reductase reaction
catalyzed by bovine heart SMP. HAR (50 lM) and NADH (5 lM, curve 1, and 20 lM,
curve 2) were present in the standard assay mixture. The activity is expressed as
lmol of NADH oxidized per minute per mg of protein.
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from that where the substrate NADH binds. Obvious questions rel-Fig. 2. Effect of ATP on the NADH:HAR reductase reaction catalyzed by different complex
ATP (100 lM) was present in the assay before the reactions were initiated by the enzyme
added (curves 1). (A) bovine heart submitochondrial particles (SMP, 5 lg/ml); (B) puriﬁe
SMP, 7 lg/ml); (D) P. denitriﬁcans plasma membrane vesicles (P-PMV, 10 lg/ml). Deamievant to this ﬁnding arise: (i) where is this site located?; (ii) what
is the mechanistic explanation of the competitive (with the sub-
strates) stimulation?; and (iii) is the allosteric nucleotide binding
relevant to physiological regulation of complex I? At present we
are unable to answer these questions in a straightforward way,
and only some possibilities merit brief discussion.
(i) The stimulatory effect of ATP is only seen if eukaryotic
enzymes are assayed (Fig. 2A–C). This could not exclude that
the effects of ATP as seen in SMP or Y-SMP are not direct but
mediated by some other membrane-bound ATP-binding
protein that interacts with complex I, thus modulating its
activity. The data shown in Fig. 2B seem to eliminate this
possibility unless the presence of such a ‘‘mediating’’ com-
ponent in complex I puriﬁed by the conventional procedure
[33] is to be postulated. The absence of ATP-dependent stim-
ulation in P. denitriﬁcans vesicles (Fig. 2D) excludes the loca-
tion an ATP-binding site on any ‘‘core’’ subunits of complex I.
In light of recent data on the subunit composition of P. den-
itriﬁcans NDH-1 [17], three homologues of mitochondrial
B17.2, AQDQ, and 13 kDa (bovine nomenclature) subunits
can also be excluded. Five nucleotide-binding subunits of
bovine heart complex I have been identiﬁed by UV-induced
photolabeling with 32P-nicotinamide adenine dinucleotides
and (b-32P)ADP [45]. The 51 and 30 kDa subunits wereI preparations. Actual tracings of NADH (5 lM) oxidation by 50 lM HAR are shown.
preparations (curves 3) or added where indicated (curves 2). No ATP was present or
d bovine heart complex I (1.5 lg/ml); (C) Y. lipolytica submitochondrial particles (Y-
no-NADH was used as the substrate in panel C.
Fig. 3. Activation of bovine heart SMP NADH:HAR reductase by adenine nucleo-
tides. The concentrations of the reactants were: NADH, 5 lM and HAR, 50 lM. The
speciﬁc activity in the absence of added nucleotides (0.1 lmol per min/mg) was
taken as 1 unit. Curves 1 and 2, ADP or ATP were added to the standard assay
mixture, respectively.
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subunit located in FP fraction, whereas the identity of the
latter could not be deﬁnitely established [45]. The eliminat-
ing effect of Mg2+ on the ATP-dependent effect (Table 1)
shows that free ATP is the activating specie. If a contaminat-
ing ‘‘mediator protein’’ proposal is to be accepted, the ATP/
ADP translocator, the most abundant protein in the inner
mitochondrial membrane, would be the best candidate for
this role. However, atractylate, the speciﬁc inhibitor of
nucleotide binding by ATP/ADP translocator did not abolish
the ATP-induced activation (Table 1), an observation which
contradicts the ‘‘contaminating mediator’’ proposal.
(ii) Whether the ATP-induced increase in NADH:HAR reductase
is direct or mediated, it appears as a substrate- and oxidant-
competitive activation, i.e. a decrease in apparent Km values
for the reactants (Fig. 4). An apparent Km for the substrate-
electron donor is a complex function of the binding term
(KS), the kinetic term (kcat), and the terms describing equilib-
ria between the primary and several consequently arranged
redox components leading to the electron acceptor reactive
site [46]. A decrease in apparent KNADHm would be expectedFig. 4. Kinetic pattern of ATP-dependent stimulation of NADH:HAR reductase catalyzed b
added. (A) 100 lM HAR was present; (B) 5 lM NADH was present.if ATP binding results in a positive shift of the midpoint
redox potential of a component which donates electrons to
HAR. The structural studies show that most of the multiple
redox components in complex I (except for FMN and iron–
sulfur clusters N-1a and N-3) are not easily accessible for
external oxidants [4]. For kinetic reasons [37,38], the redox
components located in the cavity where NADH binds
(FMN, N-1a, N-3) can hardly be assigned as the sites at
which HAR interacts with the electron acceptor. A deep
acidic groove is seen in the structure of the hydrophilic part
of Thermus thermophilus NDH-1 close to the area where the
N-2 iron–sulfur cluster is located [4]. We propose that HAR
accepts electrons from the same site (N-2) where the ﬁrst
electron is donated to the natural quinone acceptor. The
overall rates of NADH oxidase (coupled or uncoupled) or
ubiquinone reductase are evidently limited by the step(s)
that follow reoxidation of N-2, and it is not surprising that
alteration of the midpoint potential of N-2 by ATP (as we
propose) does not affect other than HAR reductase activity.
Remarkably, a mutation of Y. lipolytica 49 kDa subunit
His226 located in close vicinity (4 Å in T. thermophilus NDH-
1) of iron–sulfur cluster N-2 was shown to shift its redox
midpoint potential by 80 mV and eliminate its pH-depen-
dency without affecting either the catalytic activity or H+/e¯
proton pumping stoichiometry [47].
(iii) The only activity among several others tested in this study
that is strongly affected by ATP is NADH:HAR reductase.
We believe that stimulation of this activity should be inter-
preted as a signature of some other yet unknown function-
ally signiﬁcant effect of nucleotide binding. Relatively high
afﬁnity of ATP (ADP) for its (their) binding site (Table 1) sug-
gests that complex I in mitochondria is always present as an
allosteric nucleotide-binding site saturated form. At present
only hypothetical proposals on functional importance of ATP
binding can be offered. One possibility is that it changes an
accessibility of the protein for posttranslational modiﬁca-
tions such as, for example, phosphorylation/dephosphoryla-
tion, which in turn affects the catalytic activity of complex I.
Another possibility is that allosteric nucleotide binding
inﬂuences the interaction of complex I with other respira-
tory chain components (so-called ‘‘supercomplex’’ forma-
tion). Also, the effect of ATP binding on the resistance of
complex I to intracellular proteolysis and/or oxidative dam-
age cannot be excluded. It is pertinent to the present discus-
sion to note that allosteric binding of nucleotides ATP/ADP toy bovine heart SMP. Lines 1, controls; lines 2, 10 lM ATP (A) and 20 lM ATP (B) was
2216 V.G. Grivennikova et al. / FEBS Letters 585 (2011) 2212–2216the respiratory enzyme (complex I as reported here) is not
unique: mammalian cytochrome c oxidase was shown to
bind ATP and ADP, and this binding affects the enzyme activ-
ity [48].
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